论文部分内容阅读
文拉法辛为一种5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂,临床用于治疗抑郁症、焦虑障碍、认知损害、绝经期潮热、发作性睡病、躯体形式障碍等。随着在临床的广泛应用,其药物不良反应也逐渐引起人们重视。本文报道1例文拉法辛速释制剂所致撤药综合征,并对相关文献进行复习。患者,女性,年龄27岁,主诉少语、少动、忧愁两月余,于2011年1月6日来本院门诊,诊断抑郁症。给予国产文拉法辛胶囊(商品名:备乐,成都恒瑞制药有限公司
Venlafaxine, a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor, is clinically used to treat depression, anxiety disorders, cognitive impairment, hot flashes at menopause, narcolepsy Diseases, somatoform disorders. With the wide application in the clinic, its adverse drug reactions have gradually attracted people’s attention. In this paper, we report a withdrawal syndrome caused by venlafaxine immediate release preparation and review the relevant literature. Patient, female, age 27 years old, complains less frequently, seldom moved, sad more than two months, came to our hospital on January 6, 2011 to diagnose depression. Give homemade venlafaxine capsules (trade name: equipment music, Chengdu Hengrui Pharmaceutical Co., Ltd.